Company

A message from our CEO

Algorithme Pharma has performed thousands of clinical trials on healthy volunteers for more than 15 years and I’m proud to say that our reputation for consistent quality and scientific expertise is well deserved.

Together with our UK sister company Simbec, we have over 45 years combined experience in Phase I/IIa clinical studies and bioequivalence, offering full-service clinical contract research to our client base in North America and Europe. Our clientele includes both international and regional pharmaceutical companies, generic drug companies, and the biopharmaceutical industry.

Algorithme Pharma and Simbec work hand-in-hand to provide global early stage and bioequivalence clinical trials, regulatory expertise, protocol preparation and comprehensive support services right through to the final report. Like every other client, you benefit from our wealth of experience and can always rest assured that your study and reports will meet the regulatory and ethical standards of the countries you have chosen for submission. We believe in the partnerships we have with our clients, and we demonstrate this commitment by providing ongoing support throughout the entire regulatory process to approval.

Because we recognize the importance of our partnerships, we go the extra mile to provide the personal touch and outstanding service that makes a difference. We pride ourselves in seeking and listening to your feedback and incorporating your input in our continual efforts to ensure our services meet your requirements. It’s thanks to you that we are recognized as an industry leader.

I and my teams in Canada and the UK would be delighted to meet or speak with you to discuss ways in which we can help you meet your needs for early clinical support.  I would also be truly pleased to receive any comments you may have on our overall abilities to fulfill your requirements.

Chief Executive Officer